8-K Reg FD – Clene Inc. (0001822791) August 05
Item 7.01 Regulation FD Disclosure. On August 5, 2021, Clene Inc. (the “Company”) issued a press release announcing positive top-line results from its Phase 2 REPAIR clinical trials in Parkinson’s disease and multiple sclerosis. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated…
Read More “8-K Reg FD – Clene Inc. (0001822791) August 05” »